Cancer: Page 2

Immunovia completes development of blood test for pancreatic cancer

By Liz Carey

What's next for company after moving testing laboratory to North Carolina.

August 5, 2024

Paige releases open-source million-slide foundation model suite

By LabPulse.com staff writers

Company anticipates the development of clinical-grade products for less-common cancers.

August 1, 2024

New laboratory developed tests for colorectal cancer screening get boost from CMS

By Liz Carey

Clinical laboratory test manufacturers aim for estimated 60 million unscreened Americans as CMS meets them with a broad CRC screening test definition and proposed coverage changes in 2025.

July 31, 2024

Hologic acquires Endomag for $310M

By LabPulse.com staff writers

Hologic has completed its acquisition of breast cancer surgery technologies developer Endomagnetics (Endomag) for approximately $310 million.

July 26, 2024

Researchers develop AI model for breast tumor staging

By LabPulse.com staff writers

A team of researchers has created an artificial intelligence (AI) model that can identify the different stages of ductal carcinoma in situ, a preinvasive tumor that may progress to a lethal form of breast cancer.

July 25, 2024

New consensus report targets PGx testing for 5-FU chemotherapy toxicity

By Liz Carey

The Association for Molecular Pathology published consensus recommendations to aid in the design and validation of clinical genotyping assays that target chemotherapy toxicity concerning the dihydropyrimidine dehydrogenase protein and the DPYD gene.

July 23, 2024

Radionetics Oncology, Lilly form strategic partnership

By LabPulse.com staff writers

Biotech firm Radionetics Oncology has entered a strategic partnership with Eli Lilly for access to Radionetics' proprietary G protein-coupled receptor-targeted small molecule radiopharmaceuticals for solid tumor treatment.

July 2, 2024

Geneoscopy files countersuit against Exact Sciences in patent infringement dispute

By LabPulse.com staff writers

Geneoscopy filed a lawsuit on June 28 against Exact Sciences asserting multiple claims for damages in federal court in the District of Delaware, in the latest development in the ongoing patent dispute between the two companies.

July 1, 2024

Myriad Genetics, GSK team up for global ovarian cancer testing

By LabPulse.com staff writers

Genetic testing and precision medicine company Myriad Genetics is collaborating with GSK to improve access to homologous recombination deficiency diagnostic testing for high-grade serous ovarian cancer patients in nine countries.

June 11, 2024

Genialis, PanCAN partner to validate KRAS biomarker for pancreatic cancer

By LabPulse.com staff writers

Biomarker company Genialis and the Pancreatic Cancer Action Network (PanCAN) are collaborating to further the validation of the Genialis KrasID biomarker for pancreatic cancer using PanCAN's Know Your Tumor precision medicine service.

June 3, 2024

Guardant's CRC screening test receives advisory committee recommendation

By LabPulse.com staff writers

Guardant's blood-based Shield screening test for colorectal cancer (CRC) has received the recommendation of the U.S. Food and Drug Administration's Medical Devices Advisory Committee, an important milestone on its path to approval.

May 28, 2024

Novel oncology tests capture large share of new PLA codes effective July 1

By LabPulse.com staff writers

Deadline for next Clinical Laboratory Fee Schedule (CLFS) annual meeting in June is May 30.

May 23, 2024

Previous Page

Page 2 of 98

Next Page